Filter posts

Rare Disease Day 2014: Joining Together for Better Care

There are more than 6,000 different rare diseases affecting over 60 million people across Europe …

FDA Week: For Biologics, A Name Isn't Just A Name (Jim Greenwood op-ed)

What is in a name? Names help make medicinal products more easily distinguishable by doctors, …

Putting Patients First: Paving a Path to Useful CER

Comparative effectiveness research (CER) has the potential to improve health outcomes by helping people make …

Involving Patients in the Research Process

According to the National Psoriasis Foundation, as many as 7.5 million Americans live with psoriasis, …

Patients are the Missing Link in R&D

An architect does not wait until construction begins to show clients a blueprint. Neither does a caterer …

Psoriasis Patients Flock to Social Media for Practical Info

About eight in 10 psoriasis patients who use health care social networks say they do …

Onyx CEO One of 25 Most Influential People in Biopharm Today According to FierceBiotech

After a stellar year, as evidenced by inclusion in the second annual FierceBiotech “25 Most …

FDASIA: A Step Forward for Patients

Earlier this year, Congress passed and President Obama signed the FDA Safety and Innovation Act …

Analysis and Impact of PDUFA V

As the House of Representatives voted unanimously to approve legislation to approve the Prescription Drug …

Bringing Hope to Patients

No-one expected Hope Bartley to survive after she was born three months early. Thanks to …